Mosunetuzumab Effective for Patients With Follicular Lymphoma After at Least 2 Prior Lines of Therapy
Researchers sought to determine whether mosunetuzumab would be effective for treating relapsed/refractory FL in patients with 2 or more prior lines of therapy.